Lisa Giles invited as a guest lecturer at MATTER, Chicago’s premier healthcare incubator. She will present on October 15 on “Valuation – Building a Credible Story and Forecast.

GAC completed market research and prepare a strategic report to facilitate a manufacturing company’s future priorities to advance digital clinical healthcare delivery

GAC engaged to facilitate an Expert Panel on “The Future of Ambulatory Care and Group Medical Practices Affiliated with IDNs”

GAC completes “Oncology 2025”, a snapshot of the future drivers of change and their implication on oncology therapeutics

GAC facilitated a 2-day Strategic Plan Workshop for a major Academic Cancer Center

GAC was commissioned to design and implement a new product optimization roadmap to align a pharma company’s commercial and clinical organizations around consistent and coordinated portfolio asset selection, development and commercial preparedness


Lisa Giles acknowledged as “Pharma100 – Most Influential People in Life Sciences”

GAC completed a 5 year strategic plan for an academic medical center to prioritize its research and clinical focus in diabetes, endocrine and metabolism

An emerging biopharmaceutical company commissioned GAC to evaluate, characterize and prioritize its product portfolio across a range of markets and indications

GAC engaged to assess “The Future of Diagnostic Testing in Urgent Care and Long Term Care Centers”

GAC commissioned to assess best practices for technology conversion from academic research to the life science industry